CIRTRAN CORP 8-K
Research Summary
AI-generated summary
CIRTRAN CORP Enters $10M Standby Equity Purchase Agreement
What Happened
- CIRTRAN CORP (CIRX) announced on December 22, 2025 that it entered into a Standby Equity Purchase Agreement with YA II PN, Ltd. Under the agreement the company may, at its option, sell up to $10,000,000 of common stock to YA over a 24‑month period. The company is not obligated to sell any shares; YA’s purchases are conditioned on, among other things, an effective SEC registration statement for resale of the shares.
Key Details
- Agreement date: December 22, 2025; term: up to 24 months (or earlier if YA purchases $10M).
- Company option to direct individual purchases (“Advances”); no mandatory minimum Advance and no obligation to sell.
- Purchase price for each Advance is tied to the stock’s VWAP (company may set a minimum acceptable price); no contractual cap on price YA could pay.
- Company must issue 3,846,154 shares to YA in December 2026 (as required by the Purchase Agreement).
- Ownership cap: YA and affiliates may not beneficially own more than 4.99% of outstanding voting power/shares.
- 50% of any proceeds from sales to YA must be applied to reduce indebtedness (including accrued interest) to Tekfine, LLC; a Forbearance Agreement with Tekfine (dated Nov 26, 2025, delivered Dec 15, 2025) includes similar trading restrictions.
- YA and Tekfine agreed not to engage in short sales or establish net short positions in the common stock during the Purchase Agreement term.
Why It Matters
- This agreement gives CIRTRAN a potential equity financing source of up to $10M that it can draw on as needed, which may help fund working capital, general corporate needs, and partial repayment of debt to Tekfine.
- Because sales are at the company’s discretion (and subject to SEC registration), the arrangement provides financing flexibility without immediate dilution unless the company elects to issue shares.
- Investors should note the required issuance of shares in December 2026 and the 4.99% ownership cap for YA, along with contractual limits on short selling by YA and Tekfine, which affect potential stock supply and holder behavior.